Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25456460
DOI
10.1016/j.jns.2014.10.002
PII: S0022-510X(14)00655-8
Knihovny.cz E-resources
- Keywords
- Clinically isolated syndrom, Cognition, Gray matter, Learning effect, MRI, Multiple sclerosis,
- MeSH
- Atrophy MeSH
- Time Factors MeSH
- Adult MeSH
- Interferon beta-1a MeSH
- Interferon-beta therapeutic use MeSH
- Cognition * drug effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging * MeSH
- Brain pathology MeSH
- Follow-Up Studies MeSH
- Neuropsychological Tests MeSH
- Disease Progression MeSH
- Prospective Studies MeSH
- Multiple Sclerosis drug therapy pathology MeSH
- Gray Matter pathology MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Interferon beta-1a MeSH
- Interferon-beta MeSH
BACKGROUND: Repeated administration of Paced Auditory Serial Addition Test (PASAT) results in a considerable learning effect in short- or long-term follow-up studies. However, the relationship between PASAT learning and changes in magnetic resonance imaging (MRI) parameters is yet to be investigated. OBJECTIVES: The aim of this study is to determine if change in brain MRI metrics predicts evolution of PASAT in high functioning clinically isolated syndrome (CIS) patients on disease-modifying treatment (DMT). METHODS: This prospective 48-month observational study examined 128 CIS patients treated with 30 μg of intramuscular interferon beta-1a once a week. The correlation between PASAT and MRI measures was assessed at baseline, at 6 months and then annually over the 48-month follow up. Linear mixed model analysis adjusted for age, gender, education and DMT was used to model the temporal association between MRI measures and PASAT performance. RESULTS: MRI revealed 2.5% gray matter (GM) volume loss and 4.3 point increase in PASAT score over 48 months. MS patients evidenced significantly greater PASAT score absolute change, had lower loss of GM volume (p=.008) but not significant change in cortical (p=.061), white matter (p=.086) or whole brain volumes (p=.879). CONCLUSIONS: The present study reveals a significant relationship between higher PASAT learning effect and less GM atrophy in CIS patients on DMT. These findings suggest that change in PASAT associated more with GM than WM pathology, and that treatment strategies oriented toward GM volume preservation may play an important role in prevention of cognitive deterioration in CIS patients.
References provided by Crossref.org